These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Radiotherapy in HIV positive patients]. Lotz R; Rösler HP; Zapf S; Kutzner J; Thelen M Fortschr Med; 1990 Jan; 108(2):35-6, 39. PubMed ID: 1690165 [TBL] [Abstract][Full Text] [Related]
23. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma. Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283 [TBL] [Abstract][Full Text] [Related]
24. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057. Miles S; Levine A; Feldstein M; Carden J; Cabriallas S; Marcus S; Mitsuyasu R; Gill P Cytokines Cell Mol Ther; 1998 Mar; 4(1):17-23. PubMed ID: 9557213 [TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700 [TBL] [Abstract][Full Text] [Related]
26. Low dose recombinant interferon alfa treatment for classic Kaposi's sarcoma. Tur E; Brenner S; Michalevicz R Arch Dermatol; 1993 Oct; 129(10):1297-300. PubMed ID: 8215494 [TBL] [Abstract][Full Text] [Related]
27. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. Gill PS Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642 [TBL] [Abstract][Full Text] [Related]
28. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment. Dezube BJ Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241 [TBL] [Abstract][Full Text] [Related]
29. HIV-associated cutaneous Kaposi's sarcoma--palliative local treatment by radiotherapy. Saran FH; Adamietz IA; Thilmann C; Mose S; Böttcher HD Acta Oncol; 1997; 36(1):55-8. PubMed ID: 9090967 [TBL] [Abstract][Full Text] [Related]
30. Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial. Olweny CL; Borok M; Gudza I; Clinch J; Cheang M; Kiire CF; Levy L; Otim-Oyet D; Nyamasve J; Schipper H Int J Cancer; 2005 Feb; 113(4):632-9. PubMed ID: 15472910 [TBL] [Abstract][Full Text] [Related]
31. [Lymph drainage with secondary lymphedema caused by Kaposi sarcoma]. Einfeldt H Z Lymphol; 1992 Dec; 16(1):10-3. PubMed ID: 1288026 [TBL] [Abstract][Full Text] [Related]
32. Sclerotherapy for the treatment of nodular intraoral Kaposi's sarcoma in patients with AIDS. Muzyka BC; Glick M N Engl J Med; 1993 Jan; 328(3):210-1. PubMed ID: 8417393 [No Abstract] [Full Text] [Related]
36. HIV infection: clinical features and treatment of thirty-three homosexual men with Kaposi's sarcoma. Epstein JB; Scully C Oral Surg Oral Med Oral Pathol; 1991 Jan; 71(1):38-41. PubMed ID: 1704495 [TBL] [Abstract][Full Text] [Related]
37. Intralesional vincristine combined with cryotherapy for recalcitrant verrucas. Lee JR; Youn JH; Roh JY Dermatol Ther; 2011; 24(3):380-3. PubMed ID: 21689250 [TBL] [Abstract][Full Text] [Related]